Free Access
Med Sci (Paris)
Volume 26, Number 11, Novembre 2010
Page(s) 943 - 949
Section Resistance aux antibiotiques : un enjeu international
Published online 15 November 2010
  1. Oliveira DC, Tomasz A, Lencastre H. Secrets of success of a human pathogen : molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002 ; 2 : 180-9. [Google Scholar]
  2. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001 ; 357 : 1225-40. [Google Scholar]
  3. Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillinresistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001 ; 40 : 1-4. [Google Scholar]
  4. Ito T, Okuma K, Ma XX, et al. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome : genomic island SCC. Drug Resist Updat 2003 ; 6 : 41-52. [Google Scholar]
  5. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001 ; 9 : 486-93. [Google Scholar]
  6. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000 ; 44 : 1549-55. [Google Scholar]
  7. Ito T, Ma XX, Takeuchi F, et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004 ; 48 : 2637-51. [Google Scholar]
  8. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002 ; 46 : 2155-61. [Google Scholar]
  9. International working group on the classification of staphylococcal cassette chromosome elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009 ; 53 : 4961-7. [Google Scholar]
  10. Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009 ; 53 : 531-40. [Google Scholar]
  11. Hiramatsu K, Katayama Y, Yuzawa H, et al. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol 2002 ; 292 : 67-74. [Google Scholar]
  12. Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J Bacteriol 2003 ; 185 : 2711-22. [Google Scholar]
  13. Tsubakishita S, Kuwahara-Arai K, Baba T, et al. Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus. Antimicrob Agents Chemother 2010 ; 54 : 1469-75. [Google Scholar]
  14. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France : emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002 ; 35 : 819-24. [Google Scholar]
  15. Woodin AM. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 1960 ; 75 : 158-65. [Google Scholar]
  16. Konig B, Prevost G, Piemont Y, et al. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995 ; 171 : 607-13. [Google Scholar]
  17. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002 ; 359 : 753-9. [Google Scholar]
  18. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes : worldwide emergence. Emerg Infect Dis 2003 ; 9 : 978-84. [Google Scholar]
  19. Dauwalder O, Lina G, Durand G, et al. Epidemiology of invasive methicillinresistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008 ; 46 : 3454-8. [Google Scholar]
  20. Durand G, Bes M, Meugnier H, et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital and community-acquired infections in France. J Clin Microbiol 2006 ; 44 : 847-53. [Google Scholar]
  21. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997 ; 350 : 1670-3. [Google Scholar]
  22. Sancak B, Ercis S, Menemenlioglu D, et al. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005 ; 56 : 519-23. [Google Scholar]
  23. Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001 ; 47 : 399-403. [Google Scholar]
  24. Cui L, Iwamoto A, Lian JQ, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006 ; 50 : 428-38. [Google Scholar]
  25. Swenson JM, Anderson KF, Lonsway DR, et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2009 ; 47 : 2013-7. [Google Scholar]
  26. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007 ; 60 : 788-94. [Google Scholar]
  27. Ho PL, Lo PY, Chow KH, et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 2010 ; 60 : 140-5. [Google Scholar]
  28. Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008 ; 31 (suppl 2) : 1-9. [Google Scholar]
  29. Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004 ; 42 : 2398-402. [Google Scholar]
  30. Maclayton DO, Suda KJ, Coval KA, et al. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 2006 ; 28 : 1208-16. [Google Scholar]
  31. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008 ; 46 : 193-200. [Google Scholar]
  32. Vandenesh F, Lina G, Gillet Y et al. Chronique d’une controverse sur une bactérie équipée pour tuer. Med Sci (Paris) 2009 ; 25 : 984-6. [Google Scholar]
  33. Cattoir V, Leclercq R. Les entérocoques résistants aux glycopeptides. Med Sci (Paris) 2010 ; 26 : 936-42. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.